2021 Jun 24
MCC Member & C2i Genomics Co-Founder Dan Landau's Achievement - C2i Genomics Named Finalist for Nature’s Spinoff Prize
Early cancer detection can make all the difference for a patient. Yet many cancers aren’t diagnosed until it’s too late. Drs. Dan Landau and Asaf Zviran are working to develop ultra-sensitive blood tests – called “liquid... Read more